Search clinical trials for: relapsed fallopian tube cancer
Total 93487 results
-
Guangxi Medical UniversityNot yet recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of OvaryChina
-
Loyola UniversityKaryopharm Therapeutics IncRecruitingOvarian CancerUnited States
-
Shanghai Yunying Medical TechnologyShanghai 10th People's HospitalRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CarcinomatosisChina
-
Shanghai Gynecologic Oncology GroupFudan UniversityNot yet recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaChina
-
AGO Research GmbHGlaxoSmithKlineNot yet recruitingPrimary Peritoneal Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer
-
Jennifer Lauren KamensGateway for Cancer ResearchRecruitingAcute Myeloid LeukemiaUnited States
-
University College, LondonBarts & The London NHS Trust; Anticancer Fund, Belgium; JP Moulton Charitable...RecruitingOvarian Cancer | Fallopian Tube Cancer | Relapsed Ovarian Cancer | Peritoneal Cancer | High Grade Serous Carcinoma | Ovary Cancer | Endometrioid CarcinomaUnited Kingdom
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Clovis Oncology, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Metastatic Malignant Solid Neoplasm | Unresectable Solid NeoplasmUnited States
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
Mundipharma Research LimitedCompletedSoft Tissue Sarcoma | Ovarian Cancer | Endometrial Cancer | Small-cell Lung Cancer | Triple-negative Breast CancerUnited States, Canada
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Spain, Canada, Australia, United Kingdom, France
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Spain, Belgium, Australia, Israel, Germany, France, United Kingdom, Italy, Canada, New Zealand
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited Kingdom, United States, Israel, Spain, Italy, Czechia, Canada, Hungary, Poland, Russian Federation, Brazil, Ukraine
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Advanced Solid Tumor With Evidence of Germline or Somatic BRCAUnited States, Israel, Spain, Canada, United Kingdom
-
University of WashingtonNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
SOTIO a.s.European Network of Gynaecological Oncological Trial Groups (ENGOT)WithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal Carcinoma
-
SCRI Development Innovations, LLCGlaxoSmithKlineTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Estrogen Receptor Positive | PostmenopausalUnited States
-
Imperial College Healthcare NHS TrustCompletedRecurrent Ovarian CancerUnited Kingdom
-
Linda R DuskaNovartisCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Mixed Phenotype Acute LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal CancerUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)WithdrawnOvarian Neoplasms | Fallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer
-
CelgeneCompletedCarcinoma, Non-Small-Cell Lung | Urinary Bladder Neoplasms | Tumor Virus Infections | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Transitional Cell | Carcinoma, Pancreatic DuctalSpain, United States, France, Netherlands
-
University College, LondonCancer Research UK; Oxford BioMedicaCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited Kingdom
-
Janssen Research & Development, LLCPharmaMarCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States, Poland, United Kingdom, China, Switzerland, Israel, South Africa, Australia, Russian Federation, New Zealand
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.Withdrawn
-
National University Hospital, SingaporeKK Women's and Children's Hospital; National Cancer Centre, Singapore; Australia...UnknownOvarian Cancer | Fallopian Tube CancerSingapore, Australia
-
AstraZenecaParexelApproved for marketing
-
University of Michigan Rogel Cancer CenterTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Regeneron PharmaceuticalsNational Cancer Institute (NCI)Completed
-
Regeneron PharmaceuticalsNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterKeryx BiopharmaceuticalsCompletedOvarian CancerUnited States
-
TetraLogic PharmaceuticalsCompletedRelapsed Epithelial Ovarian Cancer | Relapsed Primary Peritoneal Cancer | Relapsed Fallopian Tube CancerUnited States
-
National Cancer Institute (NCI)CompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Primary Peritoneal NeoplasmsUnited States
-
Medical Research CouncilNational Health and Medical Research Council, Australia; AstraZeneca; Cancer... and other collaboratorsUnknownOvarian CancerUnited Kingdom
-
MorphotekCompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Germany
-
Women and Infants Hospital of Rhode IslandAmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
National Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Merck Sharp & Dohme LLCCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer
-
John Stoddard Cancer Center at Iowa Methodist Medical...UnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Mount Vernon Cancer Centre at Mount Vernon HospitalUnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
Peking University Cancer Hospital & InstituteRecruitingFallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaChina
-
Case Comprehensive Cancer CenterNot yet recruitingPancreatic Adenocarcinoma | Ovarian Cancer | Epithelial Ovarian CancerUnited States
-
National Cancer Institute (NCI)Not yet recruitingRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Undifferentiated Carcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Ovarian Undifferentiated Carcinoma and other conditions
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Not yet recruitingGynecologic Cancer | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer
-
Viracta Therapeutics, Inc.Recruiting